title: Long-term central venous catheter infection in HIV-infected and cancer patients: a multicenter cohort study.
abstract: OBJECTIVE
  To evaluate and compare the risk of long-term central venous catheter (CVC) infection in human immunodeficiency virus (HIV)-infected and cancer patients.
  
  
  METHODS
  Prospective multicenter cohort study based on active surveillance of long-term CVC manipulations and patient outcome over a 6-month period.
  
  
  METHODS
  Services of infectious diseases and oncology of 12 university hospitals in Paris, France.
  
  
  METHODS
  In 1995, all HIV and cancer patients with solid malignancy were included at the time of long-term CVC implantation.
  
  
  RESULTS
  Overall, 31.6% of long-term CVC infections were identified in 32% of 201 HIV and 5% of 255 cancer patients. Most were associated with bacteremia, most commonly coagulase-negative staphylococci. The long-term CVC time-related infection risk was greater in HIV than in cancer patients (3.78 vs 0.39 infections per 1,000 long-term CVC days; P<.001). The independent risk factors of long-term CVC infection were as follows: in HIV patients, frequency of long-term CVC handling and neutropenia; in cancer patients, poor Karnofsky performance status; in both HIV and cancer patients, recent history of bacterial infection. The risk of long-term CVC infection was similar for tunneled catheters and venous access ports in each population.
  
  
  CONCLUSIONS
  Prevention of long-term CVC infection should focus first on better sterile precautions while handling long-term CVC, especially in HIV patients who have frequent and daily use of the long-term CVC.
authors.affiliation: Centre inter-régional de coordination de la lutte contre l'infection nosocomiale, Paris-Nord, France.
authors.forename: P
authors.initials: P
authors.lastname: Astagneau
authors.forename: S
authors.initials: S
authors.lastname: Maugat
authors.forename: T
authors.initials: T
authors.lastname: Tran-Minh
authors.forename: M C
authors.initials: MC
authors.lastname: Douard
authors.forename: P
authors.initials: P
authors.lastname: Longuet
authors.forename: C
authors.initials: C
authors.lastname: Maslo
authors.forename: R
authors.initials: R
authors.lastname: Patte
authors.forename: A
authors.initials: A
authors.lastname: Macrez
authors.forename: G
authors.initials: G
authors.lastname: Brücker
mesh_terms: D016470:Bacteremia / Q000150:complications / Q000453:epidemiology / Q000382:microbiology; D001424:Bacterial Infections / Q000150:complications / Q000453:epidemiology* / Q000382:microbiology; D002175:Candida / Q000302:isolation & purification; D002405:Catheterization, Central Venous / Q000009:adverse effects* / Q000295:instrumentation; D015331:Cohort Studies; D006090:Gram-Negative Bacteria / Q000302:isolation & purification; D006095:Gram-Positive Cocci / Q000302:isolation & purification; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D015994:Incidence; D009369:Neoplasms / Q000150:complications*; D011446:Prospective Studies; D012307:Risk Factors; D013997:Time Factors